Overview

DS-5565 Phase III Study for Diabetic Peripheral Neuropathic Pain

Status:
Completed
Trial end date:
2017-06-29
Target enrollment:
Participant gender:
Summary
Investigate the efficacy and safety of DS-5565 in subjects with Diabetic Peripheral Neuropathic Pain (DPNP) in comparison to placebo
Phase:
Phase 3
Details
Lead Sponsor:
Daiichi Sankyo Co., Ltd.
Collaborators:
CMIC Co, Ltd. Japan
Quintiles Malaysia Sdn. Bhd.
Quintiles, Inc.